a.vestergaard
TL2 Moderator · Aalborg
Contributes reviews on supplier material. Based in Aalborg.
Joined 16 June 2025 · last posted 4h
84 posts, newest first. Showing up to 150.
-
How to ask a question when you cannot say why you are asking it Replied, post #54 · Start Here › How to Ask · 28 Jul 2026 · 2 likes Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is answerable. "Is this a bad idea?" without giving the context is not.
-
Seven-day rolling means and why weekly readings mislead Replied, post #120 · Outcomes › Progress reports · 27 Jul 2026 · 0 likes Rate of change: reporting progress as "lost 5 kg in 12 weeks" is more useful than "currently at 82 kg" because the rate tells you whether the change is steady,…
-
Prescription portability between countries Replied, post #111 · Access › International · 25 Jul 2026 · 1 like Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is…
-
What steady state means for the decision to escalate Replied, post #31 · Practice › Dosing & titration · 18 Jul 2026 · 0 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #71 · Practice › Dosing & titration · 17 Jul 2026 · 0 likes On post #67 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #71 · Practice › Administration · 15 Jul 2026 · 15 likes Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
-
CJC-1295 with and without DAC: what the modification does Replied, post #112 · Compounds › Secretagogues & GH axis · 15 Jul 2026 · 3 likes Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a mechanism is plausible. They cannot show magnitude of effect in humans or…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #115 · Analytics › HPLC & UHPLC · 6 Jul 2026 · 0 likes Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity…
-
Compounds this community declines to help with, and why — does this still hold? Replied, post #3 · Compounds › Other compounds · 23 Jun 2026 · 0 likes How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another. The honest position is that you are reasoning from…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #13 · Analytics › Home & field testing · 19 Jun 2026 · 0 likes Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at extremes and the correlation depends on the exact conditions…
-
Journal club: what we got wrong in an earlier session Replied, post #14 · Evidence › Journal club · 19 Jun 2026 · 0 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #74 · Safety › Contraindications · 15 Jun 2026 · 15 likes Picking up post #71: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Adjudicated events and why the definition matters Replied, post #3 · Evidence › Trials · 8 Jun 2026 · 0 likes post #2 answers the question as asked. The question underneath it is different. Surrogate endpoints: an endpoint that is not the outcome that matters but is measured as…
-
Search filters: what is missing Replied, post #61 · Meta › Site feedback · 24 May 2026 · 1 like Guideline clarity: if the guidelines are unclear or seem to be applied inconsistently, post the specific situation so staff can clarify or reconsider.
-
Tracking a shortage from primary sources rather than rumour Replied, post #15 · Access › Shortages · 20 May 2026 · 14 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #44 · Practice › Interactions · 15 May 2026 · 2 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #45 · Compounds › Tirzepatide · 12 May 2026 · 4 likes Coming back to post #43, because the follow-up matters more than the original answer. SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on…
-
Amylin receptor signalling and satiety — what changed since Replied, post #78 · Pharmacology › Receptor biology · 12 May 2026 · 29 likes post #77 answers the question as asked. The question underneath it is different. GIP receptor signalling: the glucose-dependent insulinotropic peptide receptor (GIP) is…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #74 · Outcomes › Body composition · 11 May 2026 · 16 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #128 · Analytics › Mass spectrometry · 30 Apr 2026 · 14 likes This follows post #125 rather than contradicting it. Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error large enough to…
-
Blinding yourself: practical methods and their limits Replied, post #21 · Research Methods › N-of-1 designs · 27 Apr 2026 · 5 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
What a certificate commits its issuer to — one year on Replied, post #57 · Analytics › COA interpretation · 27 Apr 2026 · 0 likes When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #57 · Practice › Administration · 26 Apr 2026 · 4 likes post #56 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Prescription requirements and telehealth models — a second dataset Replied, post #12 · Sourcing › Regulatory · 26 Apr 2026 · 0 likes Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal to purchase in another. What you can import for personal…
-
Reused chromatograms across lots: how to spot it — what changed since Replied, post #32 · Analytics › COA interpretation · 18 Apr 2026 · 4 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
Spike-and-recover accuracy for a peptide assay Replied, post #115 · Analytics › Method validation · 10 Apr 2026 · 0 likes Linearity: the detector response is proportional to compound concentration across the working range. Demonstrated by running standards at multiple concentrations and…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #93 · Practice › Reconstitution · 10 Apr 2026 · 0 likes post #92 answers the question as asked. The question underneath it is different. Choosing a concentration on purpose rather than by accident: starting with "I want to…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #52 · Pharmacology › Pharmacokinetics · 24 Feb 2026 · 6 likes Picking up post #49: that is the part I would want checked first. Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability.…
-
Trifluoroacetate content and its consequences Replied, post #67 · Analytics › Impurities & related substances · 2 Feb 2026 · 2 likes On post #63 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #19 · Practice › Storage & stability · 8 Jan 2026 · 4 likes On post #15 — agreed on the reasoning, with one qualification. Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #116 · Documentation › Doc review · 20 Dec 2025 · 0 likes New maintainer recruitment: if a page's maintainer is inactive and updates are needed, suggesting a new maintainer here can help transition responsibility.
-
Batch date after test date, and other internal inconsistencies Replied, post #23 · Analytics › COA interpretation · 3 Dec 2025 · 8 likes Worth separating two things that post #19 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
[2026 update] Long-time reader, first-time poster Replied, post #27 · Lounge › Introductions · 22 Nov 2025 · 13 likes On post #23 — agreed on the reasoning, with one qualification. Following up: if you introduce yourself and someone asks a follow-up question, you can reply here or in a…
-
Pen dose counters: what a click does and does not guarantee Replied, post #57 · Devices › Pens & autoinjectors · 16 Nov 2025 · 0 likes Visibility of the dose: some pens allow you to see the insulin remaining; others do not. Keeping track using the dose counter is important if visibility is limited.
-
About the Statistics category Replied, post #5 · Research Methods › Statistics · 12 Nov 2025 · 32 likes Number needed to treat: how many people need to be treated to prevent one bad outcome or achieve one good outcome. More intuitive than relative risk reduction.
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #69 · Practice › Dosing & titration · 30 Oct 2025 · 0 likes I read post #67 twice before replying, because I had assumed the opposite. Reaching a dose and staying there for a year: the question of whether a stable dose remains…
-
[2026 update] Scheduled maintenance and what will be unavailable Replied, post #18 · Meta › Announcements · 25 Oct 2025 · 0 likes Scheduled maintenance: if the site is going offline for maintenance, advance notice will be posted here with the duration and scope.
-
Theoretical plates: useful number or ritual? Replied, post #3 · marked as the solution · Analytics › HPLC & UHPLC · 13 Oct 2025 · 7 likes I read the opening post twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #71 · Documentation › Doc review · 9 Oct 2025 · 2 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #21 · Compounds › Semaglutide · 5 Oct 2025 · 1 like Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #33 · Wellbeing › Mental health · 3 Oct 2025 · 8 likes Mood and anxiety: mood changes and anxiety are reported by some people. Baseline mental health status matters for risk. Someone with a history of depression should plan…
-
Tracking that stops updating and then resumes — the long version Replied, post #20 · Sourcing › Logistics · 29 Sep 2025 · 0 likes Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update until it reaches the next scanning point. No update…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #24 · Practice › Storage & stability · 4 Sep 2025 · 4 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Reading SURMOUNT-1 without the press release Started this topic · Compounds › Tirzepatide · 31 Aug 2025 · 0 likes Posting this under the heading it deserves: Reading SURMOUNT-1 without the press release Everything below is what sits behind that. I have seen SURMOUNT-4 ( JAMA ,…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #100 · Data & Tools › Calculators · 31 Aug 2025 · 6 likes Precision and significant figures: the calculators do not round to match your input precision. If you input values to one decimal place, the output might have more. Use…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #109 · Evidence › Journal club · 25 Aug 2025 · 10 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #97 · Compounds › Secretagogues & GH axis · 25 Aug 2025 · 2 likes post #96 is right about the mechanism and I think understates the practical bit. Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #54 · Evidence › Journal club · 17 Aug 2025 · 9 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #80 · Access › Insurance & coverage · 14 Aug 2025 · 1 like post #79 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Are there stupid questions here? A staff answer, at length Replied, post #65 · Start Here › Welcome · 12 Aug 2025 · 29 likes The moderation log is public. Every staff action is logged with the rule cited and the reasoning stated. If you get moderated, the explanation is there and it is worth…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #97 · Compounds › Repair & healing peptides · 10 Aug 2025 · 0 likes For anyone arriving from search engines: this subcategory discusses published preclinical work and the absence of published clinical work. It does not endorse or…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #89 · Clinical › Comorbidities · 9 Aug 2025 · 1 like Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit appears to be additive to other renal-protective agents,…
-
A ten-fold dose error caught before injection — one year on Replied, post #59 · Devices › Syringes & needles · 2 Aug 2025 · 1 like Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid, puncture-resistant container). Do not put them in regular trash. Many…
-
Sequence verification for an obscure compound: how it is done Replied, post #109 · Compounds › Other compounds · 30 Jul 2025 · 11 likes When "no data" is the complete and final answer: if there is no published human data on a compound, that is the state of knowledge. Hope is not a substitute and…
-
Coming back to: Official shortage notices and what they authorise Replied, post #61 · Access › Shortages · 18 Jul 2025 · 4 likes Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on when they stopped. Gaps of months might require retitration…
-
Discussing something you have already been doing — the long version Replied, post #8 · Clinical › Prescriber conversations · 8 Jul 2025 · 0 likes Picking up post #5: that is the part I would want checked first. Questions about dose: asking "how will we determine whether this dose is working for me" gets at the…
-
Publishing an inconvenient result: a case study Replied, post #45 · Sourcing › Independent verification · 6 Jul 2025 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Which panel is worth repeating and which is worth ignoring Replied, post #54 · Clinical › Bloodwork · 6 Jul 2025 · 13 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
-
Sodium, potassium and magnesium when intake drops Replied, post #41 · Nutrition & Training › Hydration & electrolytes · 3 Jul 2025 · 5 likes Exercise and electrolyte losses: sweating during exercise increases sodium and potassium losses. Electrolyte replacement during or after intense exercise helps maintain…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #67 · Pharmacology › Pharmacokinetics · 26 Jun 2025 · 17 likes Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability. That is why the oral dose (14 mg) is so much larger than the…
-
Coming back to: When "no data" is the complete and final answer Replied, post #16 · Compounds › Other compounds · 17 Jun 2025 · 4 likes On post #12 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Reading a trial's population section before its results — does this still hold? Replied, post #115 · Evidence › Trials · 17 May 2025 · 0 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
-
Pregnancy as an absolute contraindication Replied, post #23 · Safety › Contraindications · 17 May 2025 · 1 like On post #19 — agreed on the reasoning, with one qualification. Severe hepatic impairment: less is known than for kidney disease. Extreme caution or contraindication…
-
Why the timeline is on the right and not the left Replied, post #15 · Meta › Site feedback · 7 May 2025 · 3 likes Bugs and friction: the parts of the site that do not work the way you expected. Report them specifically (what you did, what you expected, what happened instead) so…
-
Coverage for the indication versus for the drug Replied, post #45 · Access › Insurance & coverage · 28 Apr 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #138 · Sourcing › Regulatory · 26 Apr 2025 · 4 likes Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal to purchase in another. What you can import for personal…
-
Shakes versus food: a pragmatic assessment — the long version Replied, post #6 · Nutrition & Training › Protein & intake · 21 Apr 2025 · 5 likes Fibre: adequate fibre intake supports fullness and gut motility, both of which matter during the gastrointestinal effects of these compounds. High fibre on top of…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #17 · Practice › Storage & stability · 6 Apr 2025 · 5 likes Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know whether it has been sitting for weeks or days, the…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #133 · Sourcing › Vendor reports · 19 Mar 2025 · 21 likes Blind submission is worth the effort: have someone else relabel the sample so neither you nor the laboratory knows which supplier it came from until the result is back.…
-
Scheduled maintenance and what will be unavailable Replied, post #75 · Meta › Announcements · 16 Mar 2025 · 0 likes Picking up post #72: that is the part I would want checked first. Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions…
-
Second pass at: Regression to the mean in progress reports Replied, post #59 · Research Methods › Statistics · 18 Feb 2025 · 15 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #117 · Evidence › Journal club · 5 Feb 2025 · 11 likes On post #113 — agreed on the reasoning, with one qualification. SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a…
-
[2026 update] New subcategory: rationale and scope Replied, post #118 · Meta › Announcements · 3 Jan 2025 · 18 likes Archives: older announcements are archived by date. Checking archives is useful if you want to know what changed when.
-
[2026 update] New subcategory: rationale and scope Replied, post #64 · Meta › Announcements · 14 Dec 2024 · 0 likes post #63 is right about the mechanism and I think understates the practical bit. When announcements are made: major policy changes, technical changes affecting site…
-
EMA product information as a primary source — does this still hold? Replied, post #137 · Regional › European Union · 18 Nov 2024 · 6 likes EMA is the regulator with national implementation. Licensed incretin analogues are prescription-only across the EU, with some variation in specific approvals by member…
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #12 · Compounds › Semaglutide · 5 Nov 2024 · 3 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
-
Blind submission and why it changes minds Replied, post #83 · Sourcing › Independent verification · 9 Oct 2024 · 33 likes Coming back to post #81, because the follow-up matters more than the original answer. Blind sampling: submitting without the laboratory or seller knowing the source…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #8 · marked as the solution · Compounds › Other compounds · 19 Sep 2024 · 17 likes Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that regulates appetite. The documented adverse profile includes blood pressure elevation…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #50 · Analytics › COA interpretation · 9 Sep 2024 · 29 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
-
Why a preprint's supplementary material is often the best part Replied, post #13 · Evidence › Preprints · 5 Sep 2024 · 25 likes Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge. Use it for hypothesis generation and for…
-
A rising related-substance total over six months: degradation or method drift? Replied, post #3 · Analytics › Impurities & related substances · 23 Aug 2024 · 18 likes Related substances: compounds chemically related to the target peptide but not the target peptide itself. The standard method separates them and reports them as area…
-
Tracking a preprint to publication: a worked example — the long version Replied, post #27 · Evidence › Preprints · 17 Aug 2024 · 0 likes post #26 is right about the mechanism and I think understates the practical bit. Discussing preprints in this community: bring them in for early discussion, label them…
-
Guidelines revision: what changed and why Replied, post #17 · Meta › Announcements · 25 Jul 2024 · 0 likes Scheduled maintenance: if the site is going offline for maintenance, advance notice will be posted here with the duration and scope.
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #38 · Practice › Dosing & titration · 7 Jul 2024 · 11 likes Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that…